Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2010 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Neonatal apneic attack"
Page 1
Methylxanthine treatment for apnea in preterm infants.
Henderson-Smart DJ, Steer P. Henderson-Smart DJ, et al. Cochrane Database Syst Rev. 2001;(3):CD000140. doi: 10.1002/14651858.CD000140. Cochrane Database Syst Rev. 2001. PMID: 11686952 Updated. Review.
BACKGROUND: Recurrent apnea is common in preterm infants, particularly at very early gestational ages. ...REVIEWER'S CONCLUSIONS: Methylxanthines are effective in reducing the number of apneic attacks and the use of mechanical ventilation in the two to seven …
BACKGROUND: Recurrent apnea is common in preterm infants, particularly at very early gestational ages. ...REVIEWER'S CONCLUSIONS: Met …
Methylxanthine treatment for apnea in preterm infants.
Henderson-Smart DJ, Steer P. Henderson-Smart DJ, et al. Cochrane Database Syst Rev. 2000;(2):CD000140. doi: 10.1002/14651858.CD000140. Cochrane Database Syst Rev. 2000. PMID: 10796304 Updated. Review.
BACKGROUND: Recurrent apnea is common in preterm infants, particularly at very early gestational ages. ...REVIEWER'S CONCLUSIONS: Methylxanthines are effective in reducing the number of apneic attacks and the use of mechanical ventilation in the two to seven …
BACKGROUND: Recurrent apnea is common in preterm infants, particularly at very early gestational ages. ...REVIEWER'S CONCLUSIONS: Met …
Methylxanthine treatment for apnoea in preterm infants.
Henderson-Smart DJ, De Paoli AG. Henderson-Smart DJ, et al. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD000140. doi: 10.1002/14651858.CD000140.pub2. Cochrane Database Syst Rev. 2010. PMID: 21154343 Review.
Analysis was done in accordance with the recommendations of the Cochrane Neonatal Review Group. MAIN RESULTS: Six trials reported on the effect of methylxanthine in the treatment of apnoea (three trials of theophylline and three trials of caffeine). ...AUTHORS' CONCLUSIONS …
Analysis was done in accordance with the recommendations of the Cochrane Neonatal Review Group. MAIN RESULTS: Six trials reported on …